tiprankstipranks
Trending News
More News >

New Portfolio - New Portfolio

Aivo A

New Portfolio
Individual Investor
Ranked #213,876 out of 813,090 TipRanks' Investors
Success Rate
57%
29 out of 51
profitable transactions
Average Return
29.22%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 4.96%
6-Month Return▲ 28.86%
12-Month Return▲ 45.53%
YTD Return▲ 31.53%
Total Return▲ 57.61%

Best Trade

Opened at
Closed at
Gain▲ 809.68%

Bio

Performance

27.91%0-27.91%
▲ 6.03%
▲ 2.69%
▲ 1.50%
Jan 2025
▼ 12.86%
▼ 1.27%
▼ 8.78%
Feb 2025
▼ 1.80%
▼ 5.57%
▼ 4.55%
Mar 2025
▲ 1.84%
▼ 0.87%
▲ 4.63%
Apr 2025
▲ 12.20%
▲ 6.28%
▲ 12.19%
May 2025
▲ 6.24%
▲ 5.14%
▲ 11.10%
Jun 2025
▲ 27.91%
▲ 2.30%
▲ 15.52%
Jul 2025
▲ 6.81%
▲ 1.68%
▼ 1.22%
Aug 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 6.03%▲ 2.69%▲ 1.50%
▼ 12.86%▼ 1.27%▼ 8.78%
▼ 1.80%▼ 5.57%▼ 4.55%
▲ 1.84%▼ 0.87%▲ 4.63%
▲ 12.20%▲ 6.28%▲ 12.19%
▲ 6.24%▲ 5.14%▲ 11.10%
▲ 27.91%▲ 2.30%▲ 15.52%
▲ 6.81%▲ 1.68%▼ 1.22%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Nvidia
3.3%
▲ 14.64%
3
Open
Aug 12, 2025
Altimmune
4.56%
▲ 53.94%
4
Buy
Jun 26, 2025
Aeva Technologies
▲ 158.02%
2
Close
May 12, 2025
Rheinmetall
16.33%
▲ 26.28%
1
Open
Apr 07, 2025
Xeris Pharmaceuticals
5.91%
▲ 104.41%
2
Buy
Mar 11, 2025
Chimerix
▲ 809.68%
2
Close
Mar 05, 2025
Rigetti Computing
5.83%
▲ 98.04%
1
Open
Mar 05, 2025
General Dynamics
▲ 23.36%
2
Close
Feb 04, 2025
Black Diamond Therapeutics
3.66%
▲ 2.83%
1
Open
Jan 28, 2025
Outset Medical
2.2%
▼ 23.21%
1
Open
Jan 07, 2025
Tenaya Therapeutics
1.36%
▼ 75.17%
2
Buy
Dec 13, 2024
Zura Bio
1.59%
▼ 45.56%
1
Open
Dec 03, 2024
Cleanspark
4.46%
▼ 11.61%
2
Buy
Sep 03, 2024
uniQure
▲ 38.63%
2
Close
Jul 10, 2024
Oatly Group
▼ 2.33%
2
Close
May 09, 2024
Olema Pharmaceuticals
1.19%
▼ 46.04%
1
Open
May 09, 2024
EOG Resources
▲ 18.38%
2
Close
Apr 09, 2024
Lineage Therap
2.02%
▼ 27.86%
1
Open
Apr 09, 2024
Genco Shipping
▲ 13.01%
4
Close
Mar 01, 2024
Ellington Financial
3.61%
▲ 40.48%
1
Open
Mar 01, 2024